Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Chemotherapy Induced AnemiaCancer
Interventions
DRUG

peginesatide

Trial Locations (10)

Unknown

Research Facilities, Brno

Research Facility, Hradec Králové

Research Facility, Olomouc

Research Facility, Příbram

Research Facility, Gdansk

Research Facilities, Krakow

Research Facility, Lodz

Research Facility, Poznan

Research Facility, Szczecin

Research Facilities, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Affymax

INDUSTRY